Common Questions

Extraintestinal manifestations (EIMs) are complications of inflammatory bowel disease that occur outside the gut, most commonly affecting the skin, joints, eyes, and liver. They can appear before, during, or even after bowel symptoms, and some track closely with bowel inflammation while others follow their own separate course.

EIMs affect a substantial minority of people with IBD over the course of their disease, with joint involvement being the most frequent, followed by skin and eye complications. Someone can develop more than one EIM, and having one type raises the chance of developing another.

The two most recognized are erythema nodosum (tender, red nodules usually on the shins) and pyoderma gangrenosum (painful skin ulcers that can be mistaken for infection). Erythema nodosum tends to flare along with bowel inflammation, while pyoderma gangrenosum can behave more independently and needs specialized wound and medical management.

IBD-associated arthritis ranges from peripheral joint pain affecting large joints like knees and ankles (which often tracks with bowel flares) to axial disease affecting the spine and sacroiliac joints (ankylosing spondylitis and related conditions), which tends to follow its own course independent of gut symptoms.

Episcleritis (redness and irritation of the eye's surface) and uveitis (inflammation inside the eye) are the two main IBD-related eye conditions. Uveitis is more serious and requires prompt evaluation by an ophthalmologist, since untreated it can threaten vision.

Primary sclerosing cholangitis (PSC) is a chronic liver condition that scars the bile ducts, and it occurs disproportionately in people with IBD, most often ulcerative colitis or Crohn's colitis. The two conditions are managed together, often by a combined gastroenterology and hepatology team.

It depends on the type. Peripheral joint symptoms and erythema nodosum often improve alongside bowel inflammation control, while axial arthritis, uveitis, primary sclerosing cholangitis, and pyoderma gangrenosum frequently need their own targeted treatment regardless of how well the bowel disease is controlled.

Yes. Some people develop joint pain, skin changes, or eye inflammation before any bowel symptoms are recognized, which can make the underlying IBD diagnosis take longer to reach. This is one reason unexplained joint or eye symptoms sometimes prompt a gastroenterology referral.

Care is usually coordinated across a gastroenterologist and one or more specialists, rheumatology for joints, dermatology for skin, ophthalmology for eyes, and hepatology for liver involvement, working together with the IBD team rather than in isolation.

Many biologics used for IBD, particularly anti-TNF agents, also help joint, skin, and some eye manifestations, which is sometimes a factor in choosing one medication over another when a patient has significant EIM involvement.

Not necessarily in terms of bowel damage, but certain EIMs. Particularly axial arthritis and primary sclerosing cholangitis. Are associated with a more complex overall disease course and may influence treatment choices and monitoring intensity.

Yes. Chronic inflammation, corticosteroid use, and reduced activity from joint symptoms can all contribute to lower bone density in people with IBD, so bone health monitoring is often part of long-term IBD care, especially with a history of frequent steroid courses.

Anemia and clotting-related complications are common in IBD and are sometimes grouped with extraintestinal manifestations, since chronic inflammation affects the blood more broadly. IBD also carries an increased risk of blood clots, which is a consideration during flares and hospitalizations.

Both, but tell your IBD team specifically, since they can recognize a symptom as a possible extraintestinal manifestation and coordinate a fast referral to the right specialist, which can prevent delays, especially for eye symptoms that need urgent evaluation.